Atlas Trials

Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

Clinical trial NCT04989946 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04989946
Sponsor
University of Wisconsin, Madison
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2021-12-16
Primary completion
2026-12-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.